低级别浆液性卵巢癌-话题@MedSci

#低级别浆液性卵巢癌#

1篇内容 | 1448人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2265411, encodeId=69de2265411e0, content=<a href='/topic/show?id=ce9a58694b8' target=_blank style='color:#2F92EE;'>#新辅助内分泌治疗#</a> <a href='/topic/show?id=4639263155d' target=_blank style='color:#2F92EE;'>#低级别浆液性卵巢癌#</a>, objectTitle=13岁IIIC期低级别浆液性卵巢癌未检出可靶突变，获益氟维司群/哌柏西利/亮丙瑞林新型新辅助内分泌治疗, objectType=article, longId=877718, objectId=d1a58e77188a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=d1a58e77188a, replyNumber=0, likeNumber=15, createdTime=2025-05-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d1a58e77188a, moduleTitle=13岁IIIC期低级别浆液性卵巢癌未检出可靶突变，获益氟维司群/哌柏西利/亮丙瑞林新型新辅助内分泌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1a58e77188a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190224, encodeId=7bb6219022485, content=<a href='/topic/show?id=2ebf1128ef1' target=_blank style='color:#2F92EE;'>#MAPK通路#</a> <a href='/topic/show?id=4639263155d' target=_blank style='color:#2F92EE;'>#低级别浆液性卵巢癌#</a> <a href='/topic/show?id=4919109922db' target=_blank style='color:#2F92EE;'>#比美替尼#</a>, objectTitle=CCR：复发性低级别浆液性卵巢癌携带MAPK通路变异，对比美替尼和化疗均有较高的缓解率, objectType=article, longId=814879, objectId=17bd8148e924, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing-a-medical-recipe-P8LEKCP.jpg, objectUrl=/article/show_article.do?id=17bd8148e924, replyNumber=0, likeNumber=74, createdTime=2024-02-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=17bd8148e924, moduleTitle=CCR：复发性低级别浆液性卵巢癌携带MAPK通路变异，对比美替尼和化疗均有较高的缓解率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17bd8148e924)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=880516, encodeId=54ab88051603, content=<a href='/topic/show?id=4639263155d' target=_blank style='color:#2F92EE;'>#低级别浆液性卵巢癌#</a>, objectTitle= J Clin Oncol：MEK1/2抑制剂Binimetinib治疗低级别浆液性卵巢癌的疗效, objectType=article, longId=199949, objectId=9c171999498a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020826/1598435802962_2110107.PNG, objectUrl=/article/show_article.do?id=9c171999498a, replyNumber=0, likeNumber=141, createdTime=2020-08-29, rootId=0, userName=qinqiyun, userId=74c72110107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c171999498a, moduleTitle= J Clin Oncol：MEK1/2抑制剂Binimetinib治疗低级别浆液性卵巢癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c171999498a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

低级别浆液性卵巢癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#新辅助内分泌治疗# #低级别浆液性卵巢癌#

13岁IIIC期低级别浆液性卵巢癌未检出可靶突变，获益氟维司群/哌柏西利/亮丙瑞林新型新辅助内分泌治疗

2025-05-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#MAPK通路# #低级别浆液性卵巢癌# #比美替尼#

CCR：复发性低级别浆液性卵巢癌携带MAPK通路变异，对比美替尼和化疗均有较高的缓解率

2024-02-29发表于上海

qinqiyun (审核中...)

前往app查看评论内容

#低级别浆液性卵巢癌#

J Clin Oncol：MEK1/2抑制剂Binimetinib治疗低级别浆液性卵巢癌的疗效

2020-08-29

科室
- - 订阅+
  - 更多科室
工具
服务